These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33917238)

  • 1. Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate Cancer.
    Khatri W; Chung HW; Werner RA; Leal JP; Pienta KJ; Lodge MA; Gorin MA; Pomper MG; Rowe SP
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33917238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories.
    Yin Y; Werner RA; Higuchi T; Lapa C; Pienta KJ; Pomper MG; Gorin MA; Rowe SP
    J Nucl Med; 2019 Apr; 60(4):511-516. PubMed ID: 30190303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on
    Garg T; Werner RA; Chung HW; Khatri W; Pienta KJ; Pomper MG; Gorin MA; Saad E; Rowe SP
    Tomography; 2022 Oct; 8(6):2639-2647. PubMed ID: 36412679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Comparison of PET Imaging with PSMA-Targeted
    Rowe SP; Li X; Trock BJ; Werner RA; Frey S; DiGianvittorio M; Bleiler JK; Reyes DK; Abdallah R; Pienta KJ; Gorin MA; Pomper MG
    J Nucl Med; 2020 Feb; 61(2):183-188. PubMed ID: 31451492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT.
    Mihatsch PW; Beissert M; Pomper MG; Bley TA; Seitz AK; Kübler H; Buck AK; Rowe SP; Serfling SE; Hartrampf PE; Werner RA
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeatability of Quantitative
    Jansen BHE; Cysouw MCF; Vis AN; van Moorselaar RJA; Voortman J; Bodar YJL; Schober PR; Hendrikse NH; Hoekstra OS; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Predicting Metastatic Disease in
    Chiu LW; Lawhn-Heath C; Behr SC; Juarez R; Perez PM; Lobach I; Bucknor MD; Hope TA; Flavell RR
    J Nucl Med; 2020 Dec; 61(12):1779-1785. PubMed ID: 32303599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on
    Werner RA; Bundschuh RA; Bundschuh L; Javadi MS; Leal JP; Higuchi T; Pienta KJ; Buck AK; Pomper MG; Gorin MA; Lapa C; Rowe SP
    J Nucl Med; 2018 Dec; 59(12):1857-1864. PubMed ID: 30190304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with
    Werner RA; Habacha B; Lütje S; Bundschuh L; Higuchi T; Hartrampf P; Serfling SE; Derlin T; Lapa C; Buck AK; Essler M; Pienta KJ; Eisenberger MA; Markowski MC; Shinehouse L; AbdAllah R; Salavati A; Lodge MA; Pomper MG; Gorin MA; Bundschuh RA; Rowe SP
    Mol Imaging; 2022; 2022():7056983. PubMed ID: 35283693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET.
    Leung KH; Rowe SP; Leal JP; Ashrafinia S; Sadaghiani MS; Chung HW; Dalaie P; Tulbah R; Yin Y; VanDenBerg R; Werner RA; Pienta KJ; Gorin MA; Du Y; Pomper MG
    EJNMMI Res; 2022 Dec; 12(1):76. PubMed ID: 36580220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0.
    Kuten J; Dekalo S; Mintz I; Yossepowitch O; Mano R; Even-Sapir E
    EJNMMI Res; 2021 Jan; 11(1):3. PubMed ID: 33409930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement between PSMA-RADS and E-PSMA systems in classifying [
    Mendoza-Ávila M; Esparza-Pérez H; Castillo-López JA; Rodea-Montero ER
    Front Med (Lausanne); 2024; 11():1368093. PubMed ID: 38545506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
    Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY
    Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
    Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L
    BJU Int; 2020 Apr; 125(4):515-524. PubMed ID: 31957122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Center Comparison of [
    Mirzaei S; Lipp R; Zandieh S; Leisser A
    Curr Oncol; 2021 Oct; 28(5):4167-4173. PubMed ID: 34677271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging
    Chen MY; Franklin A; Yaxley J; Gianduzzo T; McBean R; Wong D; Tatkovic A; McEwan L; Walters J; Kua B
    BJU Int; 2020 Sep; 126(3):396-401. PubMed ID: 32592330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Bauman G; Martin P; Thiessen JD; Taylor R; Moussa M; Gaed M; Rachinsky I; Kassam Z; Chin J; Pautler S; Lee TY; Valliant JF; Ward A
    Eur Urol Focus; 2018 Sep; 4(5):702-706. PubMed ID: 28753797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthy Tissue Uptake of
    Jansen BHE; Kramer GM; Cysouw MCF; Yaqub MM; de Keizer B; Lavalaye J; Booij J; Vargas HA; Morris MJ; Vis AN; van Moorselaar RJA; Hoekstra OS; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2019 Aug; 60(8):1111-1117. PubMed ID: 30630941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Early and Late [
    Hohberg M; Kobe C; Täger P; Hammes J; Schmidt M; Dietlein F; Wild M; Heidenreich A; Drzezga A; Dietlein M
    Mol Imaging Biol; 2019 Jun; 21(3):558-566. PubMed ID: 30105521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.